Alexion Pharmaceuticals, Inc. (ALXN) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $118.00, up from yesterday’s close by 9.26%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
It’s important to get a feel for how any stock is actually valued on the market based on its core numbers. Alexion Pharmaceuticals, Inc. (ALXN) currently trades with a market capitalization of $26.43 Billion. That value represents a market adjusting for revenues that have been growing by 24.10 % on a quarterly year/year basis as of the company’s last quarterly report.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For ALXN, the company currently has $713 Million of cash on the books, which is offset by $167 Million current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $882.22 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $1.08 on a per share basis this quarter. Perhaps, that suggests something about why 80.86% of the outstanding share supply is held by institutional investors.
Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, Alexion Pharmaceuticals, Inc. recorded a 52-week high of $145.41. It is now trading 27.41% off that level. The stock is trading $115.06 its 50-day moving average by -2.94%. The stock carved out a 52-week low down at $96.18.
In recent action, Alexion Pharmaceuticals, Inc. (ALXN) has made a move of -1.91% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 27.88, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.79% with $223.72 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of ALXN.